Marker Therapeutics, Inc.

Monthly Archives: July 2014

TapImmune Prevails in Legal Dispute with Michael Gardner

International Arbitration Tribunal Finds in Favor of TapImmune Inc., and Awards the Company $196,204 in Damages SEATTLE–(BUSINESS WIRE)– TapImmune Inc. (TPIV), announces successful outcome of proceedings against Michael Gardner after almost 2 years of litigation.
Read More